Nicholas Restifo
Co-Founder & Chief Scientist Medici Therapeutics
Seminars
Tuesday 22nd July 2025
From Personalization to Clinical Power: How Neoantigen Vaccines Amplify the Efficacy of Cell-Based Treatments
12:30 pm
- Personalized neoantigen vaccines are now within reach for metastatic cancer patients
- On their own, these vaccines may have limited impact in advanced cancers
- Paired with cell-based treatments, they could deliver transformative results
